Literature DB >> 17573485

High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

David A Zisman1, Arun S Karlamangla, David J Ross, Michael P Keane, John A Belperio, Rajan Saggar, Joseph P Lynch, Abbas Ardehali, Jonathan Goldin.   

Abstract

BACKGROUND: Reliable, noninvasive approaches to the diagnosis of pulmonary hypertension (PH) in patients with idiopathic pulmonary fibrosis (IPF) are needed. We tested the hypothesis that chest CT-determined extent of pulmonary fibrosis and/or main pulmonary artery diameter (MPAD) can be used to identify the presence of PH in patients with advanced IPF.
METHODS: Cross-sectional study of 65 patients with advanced IPF and available right-heart catheterization and high-resolution chest CT. An expert radiologist scored ground-glass opacity, lung fibrosis, and honeycombing in the CT images on a scale of 0 to 4. These scores were also summed into a total profusion score. The main pulmonary artery was measured at its widest dimension on the supine full-chest sequence. At this same level, the widest aorta diameter was measured.
RESULTS: Chest CT-determined fibrosis score, ground-glass opacity score, honeycombing score, total profusion score, diameter of the main pulmonary artery, and the ratio of the pulmonary artery to aorta diameter did not differ between those with and without PH. There was no significant correlation between mean pulmonary artery pressure and any of the chest CT-determined measures.
CONCLUSIONS: High-resolution chest CT-determined extent of pulmonary fibrosis and/or MPAD cannot be used to screen for PH in advanced IPF patients.

Entities:  

Mesh:

Year:  2007        PMID: 17573485      PMCID: PMC2093962          DOI: 10.1378/chest.07-0116

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  41 in total

1.  Interstitial vascularity in fibrosing alveolitis.

Authors:  Elisabetta A Renzoni; David A Walsh; Michael Salmon; Athol U Wells; Piersante Sestini; Andrew G Nicholson; Srihari Veeraraghavan; Anne E Bishop; Hanna M Romanska; Panagiotis Pantelidis; Carol M Black; Roland M Du Bois
Journal:  Am J Respir Crit Care Med       Date:  2002-10-03       Impact factor: 21.405

2.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

3.  Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis.

Authors:  Masahito Ebina; Minoru Shimizukawa; Naoko Shibata; Yuichiro Kimura; Takashi Suzuki; Mareyuki Endo; Hironobu Sasano; Takashi Kondo; Toshihiro Nukiwa
Journal:  Am J Respir Crit Care Med       Date:  2004-01-30       Impact factor: 21.405

4.  Angiogenesis and pulmonary fibrosis: feast or famine?

Authors:  Michael P Keane
Journal:  Am J Respir Crit Care Med       Date:  2004-08-01       Impact factor: 21.405

5.  Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease.

Authors:  Selim M Arcasoy; Jason D Christie; Victor A Ferrari; Martin St John Sutton; David A Zisman; Nancy P Blumenthal; Alberto Pochettino; Robert M Kotloff
Journal:  Am J Respir Crit Care Med       Date:  2002-12-12       Impact factor: 21.405

6.  Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids.

Authors:  D A Zisman; J P Lynch; G B Toews; E A Kazerooni; A Flint; F J Martinez
Journal:  Chest       Date:  2000-06       Impact factor: 9.410

7.  Predicting survival of lung transplantation candidates with idiopathic interstitial pneumonia: does PaO(2) predict survival?

Authors:  Suzanne J Timmer; Amir M Karamzadeh; G L Yung; Jolene Kriett; Stewart W Jamieson; Cecilia M Smith
Journal:  Chest       Date:  2002-09       Impact factor: 9.410

8.  Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.

Authors:  Gregory P Cosgrove; Kevin K Brown; William P Schiemann; Amanda E Serls; Jane E Parr; Mark W Geraci; Marvin I Schwarz; Carlyne D Cool; G Scott Worthen
Journal:  Am J Respir Crit Care Med       Date:  2004-04-29       Impact factor: 21.405

9.  Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia.

Authors:  Vibha N Lama; Kevin R Flaherty; Galen B Toews; Thomas V Colby; William D Travis; Qi Long; Susan Murray; Ella A Kazerooni; Barry H Gross; Joseph P Lynch; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2003-08-13       Impact factor: 21.405

10.  Reference spirometric values using techniques and equipment that meet ATS recommendations.

Authors:  R O Crapo; A H Morris; R M Gardner
Journal:  Am Rev Respir Dis       Date:  1981-06
View more
  49 in total

1.  CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.

Authors:  Anand S Iyer; J Michael Wells; Sonia Vishin; Surya P Bhatt; Keith M Wille; Mark T Dransfield
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

2.  Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis.

Authors:  Anagha A Divekar; Dinesh Khanna; Fereidoun Abtin; Paul Maranian; Rajeev Saggar; Rajan Saggar; Daniel E Furst; Ram Raj Singh
Journal:  Clin Immunol       Date:  2011-09-05       Impact factor: 3.969

3.  Volume-related structures predict UIP pathology in those with a non-IPF pattern on CT.

Authors:  Jonathan H Chung; Ayodeji Adegunsoye; Justin M Oldham; Rekha Vij; Aliya Husain; Steven M Montner; Ronald A Karwoski; Brian J Bartholmai; Mary E Strek
Journal:  Eur Radiol       Date:  2021-04-13       Impact factor: 5.315

Review 4.  Cardiac manifestations of idiopathic pulmonary fibrosis.

Authors:  Abhinav Agrawal; Isha Verma; Varun Shah; Abhishek Agarwal; Rutuja R Sikachi
Journal:  Intractable Rare Dis Res       Date:  2016-05

Review 5.  Magnetic resonance and computed tomography imaging of the structural and functional changes of pulmonary arterial hypertension.

Authors:  Mark L Schiebler; Sanjeev Bhalla; James Runo; Nizar Jarjour; Alejandro Roldan; Naomi Chesler; Christopher J François
Journal:  J Thorac Imaging       Date:  2013-05       Impact factor: 3.000

6.  Pulmonary hypertension associated with lung transplantation obliterative bronchiolitis and vascular remodeling of the allograft.

Authors:  R Saggar; D J Ross; R Saggar; D A Zisman; A Gregson; J P Lynch; M P Keane; S Samuel Weigt; A Ardehali; B Kubak; C Lai; D Elashoff; M C Fishbein; W D Wallace; J A Belperio
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

7.  Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  Kyung-Hee Kim; Fabien Maldonado; Jay H Ryu; Patrick W Eiken; Thomas E Hartman; Brian J Bartholmai; Paul A Decker; Eunhee S Yi
Journal:  Respir Res       Date:  2010-04-14

8.  Evaluation of recently validated non- invasive formula using basic lung functions as new screening tool for pulmonary hypertension in idiopathic pulmonary fibrosis patients.

Authors:  Maha K Ghanem; Hoda A Makhlouf; Gamal R Agmy; Hisham M K Imam; Doaa A Fouad
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

9.  CT scanning in the evaluation of pulmonary hypertension.

Authors:  Jennifer C Kam; Justin Pi; Vikram Doraiswamy; Yaser Elnahar; Sami Abdul-Jawad; Vincent A DeBari; Alan J Klukowicz; Fayez Shamoon; Richard A Miller
Journal:  Lung       Date:  2013-05-29       Impact factor: 2.584

10.  Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  Laith Alkukhun; Xiao-Feng Wang; Mostafa K Ahmed; Manfred Baumgartner; Marie M Budev; Raed A Dweik; Adriano R Tonelli
Journal:  Respir Med       Date:  2016-06-02       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.